Rheumatic myocarditis

disease
On this page

Also known as acute rheumatic myocarditisacute rheumatic myocarditis (disorder) [ambiguous]

Summary

Rheumatic myocarditis (MONDO:0004582) is a disease. A subtype of myocarditis — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

FieldValue
Canonical namerheumatic myocarditis
Mondo IDMONDO:0004582
DOIDDOID:8481
ICD-10-CMI09.0
ICD-111177212968
NCITC35202
SNOMED CT195136004
UMLSC0155557
MedGen56370
GARD0024072
Is cancer (heuristic)no

Also known as: acute rheumatic myocarditis · acute rheumatic myocarditis (disorder) [ambiguous] · rheumatic myocarditis

Disease family

This is a subtype of myocarditis. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › musculoskeletal system disordermuscle tissue disordercardiomyopathyintrinsic cardiomyopathymyocarditisrheumatic myocarditis

Related subtypes (6): Fiedler’s myocarditis, bacterial myocarditis, acute myocarditis, interstitial myocarditis, autoimmune myocarditis, viral myocarditis

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.